知镜 Cognispect · 医学文献与研究工作台

Comparative Outcomes of Systemic Immunomodulatory Therapy Versus Local Corticosteroid Therapy in Chronic Noninfectious Uveitis.

Zhang C, Ersan S, Miguez S, Walsh HL, Kapadia KB, Yannuzzi NA, Yeh S, Albini TA.
Ocular immunology and inflammation · 2026-10-28 · PMID 42950230

文献摘要

Purpose Chronic uveitis is a significant cause of visual impairment. Although initial therapy relies on corticosteroids, patients with chronic inflammation often require systemic immunomodulatory therapy (IMT) or local sustained-release steroids. However, comparative long-term outcomes of these treatment approaches remain unclear. Methods This retrospective cohort study used the TriNetX Network to identify adults (ages ≥ 18 years) with chronic uveitis treated with systemic IMT or local corticosteroid therapy. Baseline characteristics were balanced using propensity score matching (PSM). Incidence of ocular outcomes including intraocular pressure (IOP)-lowering medication use, glaucoma, incisional glaucoma surgery, cataract surgery, cystoid macular edema (CME), and epiretinal membrane (ERM) were assessed at 1, 2, and 3 years. Outcome proportions were compared between groups using risk ratios (RR), with p Results Of 4,683 patients meeting inclusion criteria (1,273 on local therapy; 3,410 on systemic IMT), 1,087 patients remained per group after PSM. By 3 years, patients treated with local therapy had a higher cumulative incidence of IOP-lowering medication use (12.9% vs 6.9%; RR 1.88, p p p = 0.03), and cataract surgery (7.7% vs 3.5%; RR 2.24, p p p Conclusion Local corticosteroid therapy was associated with a higher cumulative incidence of complications compared to systemic IMT in patients with chronic uveitis.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。